Montanide ISA51
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Montanide ISA51, covering 2022-04-07 to 2022-04-07. Get the full timeline:
Most recent: Clinical Trial Update: Immunization With 8 Peptides Mixed With CpG 7909 or Montanide ISA51 in Patients With Metastatic Cutaneous Melanoma [Phase 1, Phase 2]